Arthur Koch, Jr.

Arthur Koch, Jr. is the Chief Financial Officer at Maxona Pharmaceuticals. Arthur has over 25 years of experience in the pharmaceutical and healthcare industries.

Arthur began their career in 1992 as the CFO of IBAH, Inc. Arthur then became the CFO of Paracelsian, Inc. in 1994. In 1996, they joined Strategic Diagnostics as the Interim CEO, COO, and CFO. Arthur remained with the company for nine years before joining Impax Laboratories as EVP & CFO in 2005.

Arthur has a proven track record of success in financial leadership roles. Arthur has extensive experience in accounting, finance, and operations. Arthur is a strategic thinker who can think outside the box to solve problems and create value for shareholders.

Arthur has a Bachelor of Science in Accounting from the University of Pennsylvania and a Master of Business Administration from the Wharton School of Business.

Arthur Koch, Jr. earned their Bachelor of Business Administration (BBA) from Temple University with dual concentrations in finance and accounting.

They work with Bob Rappaport - Chief Regulatory Advisor, Roy Freeman - Chief Medical Advisor, and Edward Allera - GC & Chief Legal Advisor. Arthur Koch, Jr. reports to Shawn Fatholahi, President & CEO.